Home
Site Search
Use small fonts Use medium fonts Use large fonts Email link to page

Resources

Related expertise

Cassels Brock Represents the Underwriters in Khiron's $28.75 Million Bought Deal Financing

Published: 05/28/2019

Team: Nancy Choi, Florence Lau, Christopher B. Norton

On May 28, 2019, Khiron Life Sciences Corp. completed a bought deal short form prospectus offering of common shares, including the exercise in full of the over-allotment option. A total of 9,914,150 shares were sold at a price of $2.90 per share for aggregate gross proceeds of approximately $28.75 million.  

The offering was completed by a syndicate of underwriters co-led by joint bookrunners Canaccord Genuity Corp. and BMO Capital Markets, and including AltaCorp Capital Inc. and Scotia Capital Inc.

Cassels Brock acted for the underwriters with a deal team that included Nancy Choi and Florence Lau (Securities and Cannabis) and Chris Norton (Tax).